• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: IANTECH, INC. MILOOP LENS FRAGMENTATION DEVICE; OPHTHALMIC HOOK

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

IANTECH, INC. MILOOP LENS FRAGMENTATION DEVICE; OPHTHALMIC HOOK Back to Search Results
Model Number FG-11881
Device Problem Insufficient Information (3190)
Patient Problems Capsular Bag Tear (2639); Vitrectomy (2643); Foreign Body In Patient (2687)
Event Date 08/16/2018
Event Type  Injury  
Manufacturer Narrative
The device was returned to iantech, decontaminated, and subjected to visual inspection and mechanical functional testing.The visual inspection revealed no damage and the device performed as expected.The reported problem could not be reproduced and the cause of the event remains undetermined.The device history records were reviewed for this manufacturing lot and there were no discrepancies or unusual findings that relate to the reported event.Capsular bag damage and dropped nuclear fragments are inherent risks of cataract surgery.[reference: schaal s, nesmith blw, ihnen ma, al-latayfeh m.Current medical and surgical management of retained lens fragments after cataract extraction.Us ophthalmic review 2014;7(2):95-99].(b)(4).
 
Event Description
A patient underwent cataract surgery on (b)(6) 2018 where the miloop device was used to section the cataractous lens into fragments.During the procedure the loop was partially deployed when the remainder of the loop deployed unexpectedly.The surgeon retracted and redeployed the loop ensuring the entire loop was under the capsulorhexis.The loop was then rotated past the midline, returned to midline and bisected and the distal nucleus prolapsed slightly.A second instrument was used to free the loop and rotate the nucleus.The surgeon noticed that the distal nucleus was still tilted up and the proximal still down in the bag and the nucleus was moving around too much and a decision was made to remove the miloop from the eye, at which time clear fluid (believed to be vitreous fluid) was observed on the loop.The surgeon proceeded with phacoemulsification and 2/3 of way through the procedure there was vitreous loss (from a posterior capsular bag tear) and a lens fragment dislocated into the vitreous.A vitrectomy was performed and an anterior chamber intraocular lens was implanted and the incision was sutured.The patient was referred to a retina specialist for retrieval of the dropped nuclear fragment.Additional information is being requested.
 
Event Description
The following additional information was provided by the surgeon.Preoperatively, the patient's best corrected visual acuity (bcva) in the operative (left) eye was 20/40-.The capsular bag damage consisted of: posterior capsule tear, zonular tear, vitreous loss, and dropped nucleus fragment.A pars plana vitrectomy was performed on (b)(6) 2018 and there was no sequelae from the dropped nuclear fragment.The patient's bcva improved to 20/25- at last examination on (b)(6) 2018 and the prognosis is good.Suture removal should reduce astigmatism and the surgeon expects the patient's vision and corneal surface to continue to improve.
 
Manufacturer Narrative
As reported in the initial report, the device evaluation findings demonstrated that the device performed as expected and no device malfunction was identified.The cause of the event remains undetermined.Capsular rupture is listed in the device labeling as an inherent risk of endocapsular lens fragmentation.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MILOOP LENS FRAGMENTATION DEVICE
Type of Device
OPHTHALMIC HOOK
Manufacturer (Section D)
IANTECH, INC.
8748 technology way
reno NV 89521
MDR Report Key7875286
MDR Text Key120241127
Report Number3012123033-2018-00007
Device Sequence Number1
Product Code HNQ
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 12/10/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/13/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/25/2019
Device Model NumberFG-11881
Device Lot NumberFG20180326-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/20/2018
Date Manufacturer Received11/20/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
OPHTHALMIC INSTRUMENT (NOT SPECIFIED); PHACOEMULSIFICATION EQUIPMENT
Patient Outcome(s) Required Intervention;
Patient Age75 YR
-
-